President Trump is expected to sign an executive order on Thursday that would reschedule marijuana to a lower drug classification, according to two sources familiar with the planning, in one of the ...

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

Dec 19 (Reuters) - AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon to announce agreements with the U.S. government to lower certain prescription drug ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...